Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
24 IU intranasal oxytocin
DRUG
2 trials
Sponsors
OptiNose AS
, Icahn School of Medicine at Mount Sinai
Conditions
Borderline Personality Disorder
Healthy Male Adults
Phase 1
Effects of Intranasal Administration of a Single Dose of Oxytocin Using a Novel Device in Healthy Adults
Completed
NCT01983514
OptiNose AS
Healthy Male Adults
Start: 2013-10-31
End: 2014-02-28
Updated: 2014-04-23
Unknown Phase
The Effect of Oxytocin Administration on Interpersonal Cooperation in Borderline Personality Disorder Patients and Healthy Adults
Suspended
NCT02225600
Icahn School of Medicine at Mount Sinai
Borderline Personality Disorder
Start: 2014-08-26
End: 2027-12-01
Target: 40
Updated: 2026-07-02
Related Papers
Low dose intranasal oxytocin delivered with Breath Powered device dampens amygdala response to emotional stimuli: A peripheral effect-controlled within-subjects randomized dose-response fMRI trial.
2016-04-22
79 citations